美农生物：2025年前三季度净利润约4092万元

Group 1 - The core viewpoint of the article highlights the financial performance of Meino Biological for the third quarter of 2023, showing significant growth in revenue and net profit compared to the previous year [1] Group 2 - For the first three quarters of 2025, Meino Biological reported revenue of approximately 390 million yuan, representing a year-on-year increase of 14.68% [1] - The net profit attributable to shareholders of the listed company was approximately 40.92 million yuan, reflecting a year-on-year increase of 29.44% [1] - The basic earnings per share were 0.2902 yuan, which is a year-on-year increase of 32.51% [1] Group 3 - As of the report date, Meino Biological's market capitalization stood at 2.6 billion yuan [2]